Absci Corporation (ABSI) NASDAQ
6.38
-0.45(-6.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Absci Corporation
Address
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
United States of America (the)
Phone
360 949 1041
Website
Sector
Healthcare
Industry
Biotechnology
Employees
156
First IPO Date
July 22, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Sean McClain | Founder, Chief Executive Officer, President & Director | 1.08M | 1990 |
| Zachariah Jonasson | Chief Business Officer & Chief Financial Officer | 816,507 | 1973 |
| Amer-Denis Akkad | Vice President of Research | 0 | N/A |
| Amir Shanehsazzadeh | Chief AI Officer | 0 | N/A |
| Shelby Walker | Chief Legal Officer | 0 | 1975 |
| Christine Lemke | Senior Vice President of Portfolio & Growth Strategy | 0 | N/A |
| Anders Kassow | Head of Intellectual Property | 0 | N/A |
| Ransi Somaratne FACC | Chief Medical Officer | 0 | 1966 |
| Melissa Patterson | Chief of Staff | 0 | N/A |
| Alexander Khan | CVP of Finance & Head of Investor Relations | 0 | N/A |
| Todd Bedrick | Senior Vice President & Chief Accounting Officer | 0 | N/A |
| Jeanne Schreuder SPHR | Senior Vice President of People & Experience | 0 | N/A |
| Wen Sha | Chief of Staff | 0 | N/A |
| Karin Wierinck | Chief People Officer | 0 | N/A |
Description
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
